Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3227401000168113 | chondroitin sulfate sodium 40 mg / 1 mL + hyaluronate sodium 30 mg / 1 mL intraocular injection, 0.5 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3227411000168111 | chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Is a | chondroitin sulfate + hyaluronate sodium | false | Inferred relationship | Some | ||
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Is a | medicinal product unit of use | false | Inferred relationship | Some | ||
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has manufactured dose form | intraocular injection | false | Inferred relationship | Some | ||
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has unit of use | syringe | false | Inferred relationship | Some | 2014372885 | |
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has Australian BoSS | chondroitin sulfate sodium | false | Inferred relationship | Some | 495439127 | |
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has intended active ingredient | chondroitin sulfate | false | Inferred relationship | Some | 495439127 | |
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has intended active ingredient | hyaluronate sodium | false | Inferred relationship | Some | 2014372884 | |
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has Australian BoSS | hyaluronate sodium | false | Inferred relationship | Some | 2014372884 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Viscoat intraocular injection, 0.5 mL syringe | Is a | False | chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Inferred relationship | Some | |
chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has MPUU | False | chondroitin sulfate sodium 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Inferred relationship | Some | 1 |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set